Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the U.S. FDA has approved Restylane Contour for the correction of temple hollowing in patients over the age of 21.
Margin trading, by which investors borrow money from brokerages using cash or existing securities as collateral to finance ...
As South Africa scales up utility-scale solar, what needs to be done well from the start? Find out from the very highly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results